Abstract:Objective: This study aims to investigate the relationship between thyroid function and prognosis in acute coronary syndrome (ACS) patients after percutaneous coronary intervention (PCI). Methods: According to the thyroid function status of the patients at admission, they were divided into the euthyroid group (Group A), subclinical hyperthyroidism group (Group B), subclinical hypothyroidism group (Group C), and low T3 group (Group D). The clinical data of the four patient groups were compared. The logistic regression model was used to analyze the relationship between thyroid function and postoperative outcomes in patients with ACS undergoing PCI. Results: A total of 200 ACS patients who underwent PCI treatment in our hospital from January 2022 to October 2023 were selected as the research population. The incidences of subclinical hyperthyroidism, subclinical hypothyroidism, and low T3 syndrome were 17.00% (34/200), (36/200), and 29.50% (59/200), respectively. Univariate analysis of variance showed significant differences in age, diabetes, smoking history, systolic pressure and heart rate at admission, shock index, blood urea nitrogen (BUN), Cr, glucose (GLU), fibrinogen (FIB), glycosylated hemoglobin (HbA1c), creatine kinase isoenzyme (CK-MB), and CRP among all groups (p < 0.05). Thyroid function markers differed significantly across the groups (p < 0.001). Specifically, Group B exhibited the lowest thyroid stimulating hormone (TSH) levels (0.23 ± 0.09 mIU/L), whereas Group C displayed the highest (8.05 ± 3.72 mIU/L). Group D showed the lowest free triiodothyronine (FT3) levels (2.74 ± 0.51 pmol/L), and Group B had the highest free thyroxine (FT4) levels (16.31 ± 2.62 pmol/L). A significant difference in the incidences of cardiovascular death and heart failure was observed among the four groups (p < 0.05). Notably, Group D showed higher incidences of cardiovascular death (11.86%) and heart failure (50.85%). Similarly, at 1-year follow-up, a significant difference in the incidences of cardiovascular death and heart failure were found among the four groups (p < 0.05). Specially, Group D exhibited higher rates of cardiovascular death (15.25%) and heart failure (27.12%). Logistic regression analyses highlighted FT3 as a significant predictor of adverse events during hospitalization (OR = 0.335, 95% CI: 0.222–0.506, p < 0.001), while TSH emerged as an independent risk factor for adverse events during 1-year follow-up (OR = 1.136, 95% CI: 1.040–1.240, p = 0.005). Conclusion: Patients with ACS have a higher incidence of mild thyroid dysfunction. Compared with patients with euthyroid function, patients with low triiodothyronine (T3) syndrome have a worse prognosis after PCI treatment. Serum FT3 concentration and TSH can be used as predictors of poor prognosis in ACS patients.

Impact of Basic Thyroid Hormone Level on Prognosis of Patients With Heart Transplantation

Alteration of Thyroid-Related Hormones Within Normal Ranges and Early Functional Outcomes in Patients with Acute Ischemic Stroke

Low T3 Syndrome is Associated with Poor Prognosis in Patients with Hepatitis B Virus-Related Acute-on-chronic Liver Failure

Prognostic Value of Free Triiodothyronine Level in Patients with Hypertrophic Obstructive Cardiomyopathy

The Association of Donor Thyroid Hormone Supplementation on Heart Transplant Recipient Survival

Long-term prognostic value of lowering in free triiodothyronine in patients with hypertrophic cardiomyopathy

The impact of serum thyroid-stimulation hormone levels on the outcome of hepatitis B virus related acute-on-chronic liver failure: an observational study

Correlation Between Thyroid Hormone Levels and Long-Term Survival in Patients with Chronic Heart Failure

Prognostic role and relationship of thyroid dysfunction and lipid profile in hospitalized heart failure patients

Relationship of Low FT3 Levels and Prognosis in Patients with Acute Coronary Syndrome

Association of Free Triiodothyronine with Long-Term Prognosis in Hypertrophic Cardiomyopathy Patients with HFpEF: A Dual Center Research Study

Donor thyroid hormone therapy and heart transplantation outcomes: ISHLT transplant registry analysis

The discussion of the relationship between cardiopulmonary bypass and postoperative thyroid function changes in pediatric congenital heart disease, and the analysis of oral thyroid hormone therapy and cardiac prognosis

Association between Thyroid Function and Postoperative Outcomes in Patients with Acute Coronary Syndrome after Treatment with PCI: A Retrospective Study

Long-term prognostic value of thyroid hormones in left ventricular noncompaction

High-Normal Thyroid Function and Recurrence of Atrial Fibrillation after Catheter Ablation: A Prospective Observational Study

Effect of Preoperative Thyroid Hormone Supplement on Cardiopulmonary Bypass in Children

Subclinical Hypothyroidism Affects the Long-Term Outcomes of Patients Who Undergo Coronary Artery Bypass Grafting Surgery but Not Heart Valve Surgery

Correlation of Triiodothyronine Level with In-Hospital Cardiac Function and Long-Term Prognosis in Patients with Acute Myocardial Infarction

The severity of valvular heart disease in euthyroid individuals is associated with thyroid hormone levels but not with TSH levels

The Impact of Subclinical Hyperthyroidism on Cardiovascular Prognosis in Patients Undergoing Percutaneous Coronary Intervention.